Moderna, Merck's Groundbreaking Melanoma Treatment Shows Promise in Combination Therapy Study
The collaborative effort harnesses Merck's expertise in immuno-oncology and Moderna's innovative mRNA technology to make a meaningful impact on patient outcomes.
University Of Miami United States Michael Casa Nova Joe Raedle Getty Keytruda Pembrolizumab Kyle Holen
Source: techtimes.com